qiagen n.v. (QGEN:NASDAQ GS)
Transactions by QIAGEN N.V. (QGEN) in the last 6 months
Qiagen NV (NASDAQ: QGEN) acquired Ingenuity Systems, Inc. for approximately $110 million in cash on April 29, 2013. Transaction has been funded from existing cash reserves. Ingenuity reported net sales of approximately $20 million, for the year ending December 31, 2012. Many members of Ingenuity's senior management team, including Jake Leschly, will continue with QIAGEN, and the offices will remain in Redwood City, California. The transaction is expected to be dilutive ...
Drug Response Dx GmbH announced that it has received its seed round of funding from new investors Qiagen NV and High-Tech Gründerfonds Management GmbH on January 7, 2013. Qiagen NV has made a strategic equity investment in the company. The terms of the transaction were not disclosed. High-Tech Gründerfonds Management GmbH invested through its fund High-Tech Gründerfonds II GmbH und Co. KG.
High-Tech Gründerfonds Management GmbH
|Bio-Rad Laboratories Inc||$113.05 USD||-1.03|
|Hologic Inc||$20.43 USD||-0.61|
|Myriad Genetics Inc||$25.88 USD||-0.56|
|PerkinElmer Inc||$33.66 USD||-0.75|
|View Industry Companies|
Post a JobJobs
- Chicago, IL | DunnhumbyusaPosted: Jun 18
- Thomasville, GA | Flowers FoodsPosted: Jun 07
- San Francisco, CA | YelpPosted: Jun 06
- San Francisco, CA | PeoplematterPosted: Jun 06